Perspective Therapeutics, Inc. (CATX)
USD 2.56
(3.64%)
USD 2.56
(3.64%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 58.09 Million USD | -9.85% |
| 2021 | 64.43 Million USD | -8.49% |
| 2020 | 70.41 Million USD | 709.47% |
| 2019 | 8.69 Million USD | -7.67% |
| 2018 | 9.42 Million USD | 26.38% |
| 2017 | 7.45 Million USD | -39.24% |
| 2016 | 12.26 Million USD | -32.22% |
| 2015 | 18.1 Million USD | -21.31% |
| 2014 | 23 Million USD | -13.36% |
| 2013 | 26.54 Million USD | 276.3% |
| 2012 | 7.05 Million USD | -6.0% |
| 2011 | 7.5 Million USD | -4.86% |
| 2010 | 7.88 Million USD | -0.68% |
| 2009 | 7.94 Million USD | -32.35% |
| 2008 | 11.74 Million USD | -34.08% |
| 2007 | 17.81 Million USD | -31.69% |
| 2006 | 26.07 Million USD | 361.04% |
| 2005 | 5.65 Million USD | -82.64% |
| 2004 | 32.58 Million USD | 0.0% |
| 2002 | 926.00 USD | 0.0% |
| 2001 | 926.00 USD | 0.0% |
| 2000 | 926.00 USD | -3.44% |
| 1999 | 959.00 USD | 0.42% |
| 1998 | 955.00 USD | -99.92% |
| 1997 | 1.17 Million USD | -10.5% |
| 1996 | 1.31 Million USD | -24.64% |
| 1995 | 1.74 Million USD | -11.34% |
| 1994 | 1.96 Million USD | -31.74% |
| 1993 | 2.87 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 110.51 Million USD | -8.01% |
| 2022 FY | 58.09 Million USD | -9.85% |
| 2022 Q1 | 62.53 Million USD | -2.95% |
| 2022 Q2 | 58.27 Million USD | -6.81% |
| 2022 Q3 | 127.64 Million USD | 119.03% |
| 2022 Q4 | 120.14 Million USD | -5.88% |
| 2021 Q2 | 67.25 Million USD | -2.12% |
| 2021 Q4 | 64.43 Million USD | -2.53% |
| 2021 Q1 | 68.71 Million USD | -2.42% |
| 2021 FY | 64.43 Million USD | -8.49% |
| 2021 Q3 | 66.11 Million USD | -1.69% |
| 2020 Q4 | 70.41 Million USD | -1.21% |
| 2020 Q2 | 15.51 Million USD | 93.31% |
| 2020 Q1 | 8.02 Million USD | -7.75% |
| 2020 FY | 70.41 Million USD | 709.47% |
| 2020 Q3 | 71.28 Million USD | 359.49% |
| 2019 Q4 | 8.69 Million USD | -2.93% |
| 2019 Q1 | 10.12 Million USD | 7.45% |
| 2019 FY | 8.69 Million USD | -7.67% |
| 2019 Q2 | 8.93 Million USD | -11.76% |
| 2019 Q3 | 8.96 Million USD | 0.32% |
| 2018 Q3 | 10.57 Million USD | -11.18% |
| 2018 Q1 | 13.34 Million USD | 78.99% |
| 2018 Q2 | 11.91 Million USD | -10.74% |
| 2018 Q4 | 9.42 Million USD | -10.94% |
| 2018 FY | 9.42 Million USD | 26.38% |
| 2017 Q4 | 7.45 Million USD | -10.42% |
| 2017 FY | 7.45 Million USD | -39.24% |
| 2017 Q3 | 8.32 Million USD | -11.26% |
| 2017 Q2 | 9.37 Million USD | -13.01% |
| 2017 Q1 | 10.78 Million USD | -12.13% |
| 2016 FY | 12.26 Million USD | -32.22% |
| 2016 Q3 | 13.94 Million USD | -6.97% |
| 2016 Q1 | 16.68 Million USD | -7.83% |
| 2016 Q4 | 12.26 Million USD | -11.99% |
| 2016 Q2 | 14.98 Million USD | -10.19% |
| 2015 FY | 18.1 Million USD | -21.31% |
| 2015 Q3 | 19.79 Million USD | -4.57% |
| 2015 Q2 | 20.74 Million USD | -5.32% |
| 2015 Q4 | 18.1 Million USD | -8.56% |
| 2015 Q1 | 21.9 Million USD | -4.76% |
| 2014 Q4 | 23 Million USD | -2.46% |
| 2014 Q2 | 24.58 Million USD | -3.74% |
| 2014 FY | 23 Million USD | -13.36% |
| 2014 Q1 | 25.53 Million USD | -3.8% |
| 2014 Q3 | 23.58 Million USD | -4.07% |
| 2013 FY | 26.54 Million USD | 276.3% |
| 2013 Q1 | 9.33 Million USD | 32.31% |
| 2013 Q4 | 26.54 Million USD | -2.39% |
| 2013 Q3 | 27.19 Million USD | 232.21% |
| 2013 Q2 | 8.18 Million USD | -12.29% |
| 2012 Q1 | 9.65 Million USD | 28.69% |
| 2012 Q2 | 8.71 Million USD | -9.76% |
| 2012 Q3 | 7.88 Million USD | -9.49% |
| 2012 Q4 | 7.05 Million USD | -10.58% |
| 2012 FY | 7.05 Million USD | -6.0% |
| 2011 Q4 | 7.5 Million USD | -1.12% |
| 2011 FY | 7.5 Million USD | -4.86% |
| 2011 Q3 | 7.59 Million USD | -10.15% |
| 2011 Q2 | 8.44 Million USD | 20.35% |
| 2011 Q1 | 7.01 Million USD | -11.02% |
| 2010 Q2 | 8.95 Million USD | 27.2% |
| 2010 Q3 | 8.43 Million USD | -5.86% |
| 2010 Q4 | 7.88 Million USD | -6.45% |
| 2010 FY | 7.88 Million USD | -0.68% |
| 2010 Q1 | 7.04 Million USD | -11.34% |
| 2009 Q3 | 8.8 Million USD | -10.35% |
| 2009 Q4 | 7.94 Million USD | -9.83% |
| 2009 FY | 7.94 Million USD | -32.35% |
| 2009 Q2 | 9.82 Million USD | -10.33% |
| 2009 Q1 | 10.95 Million USD | -6.68% |
| 2008 Q1 | 16.14 Million USD | -9.36% |
| 2008 Q4 | 11.74 Million USD | -10.88% |
| 2008 FY | 11.74 Million USD | -34.08% |
| 2008 Q3 | 13.17 Million USD | -8.93% |
| 2008 Q2 | 14.46 Million USD | -10.39% |
| 2007 Q1 | 25.05 Million USD | -3.93% |
| 2007 Q4 | 17.81 Million USD | -8.07% |
| 2007 Q2 | 21.99 Million USD | -12.2% |
| 2007 Q3 | 19.37 Million USD | -11.91% |
| 2007 FY | 17.81 Million USD | -31.69% |
| 2006 FY | 26.07 Million USD | 361.04% |
| 2006 Q4 | 26.07 Million USD | -3.76% |
| 2006 Q2 | 7.91 Million USD | -9.04% |
| 2006 Q1 | 8.7 Million USD | 53.84% |
| 2006 Q3 | 27.09 Million USD | 242.33% |
| 2005 Q2 | 3.86 Million USD | 51.29% |
| 2005 FY | 5.65 Million USD | -82.64% |
| 2005 Q4 | 5.65 Million USD | -7.09% |
| 2005 Q3 | 6.08 Million USD | 57.59% |
| 2005 Q1 | 2.55 Million USD | 0.0% |
| 2004 Q1 | 926.00 USD | 0.0% |
| 2004 FY | 32.58 Million USD | 0.0% |
| 2004 Q3 | 926.00 USD | 0.0% |
| 2004 Q2 | 926.00 USD | 0.0% |
| 2003 Q2 | 926.00 USD | 0.0% |
| 2003 Q4 | 926.00 USD | 0.0% |
| 2003 Q3 | 926.00 USD | 0.0% |
| 2003 Q1 | 926.00 USD | 0.0% |
| 2002 Q2 | 926.00 USD | 0.0% |
| 2002 Q3 | 926.00 USD | 0.0% |
| 2002 Q1 | 926.00 USD | 0.0% |
| 2002 Q4 | 926.00 USD | 0.0% |
| 2002 FY | 926.00 USD | 0.0% |
| 2001 FY | 926.00 USD | 0.0% |
| 2001 Q1 | 926.00 USD | 0.0% |
| 2001 Q2 | 926.00 USD | 0.0% |
| 2001 Q3 | 926.00 USD | 0.0% |
| 2001 Q4 | 926.00 USD | 0.0% |
| 2000 Q3 | 926.00 USD | -99.02% |
| 2000 Q2 | 94.07 Thousand USD | 9709.91% |
| 2000 Q1 | 959.00 USD | -2.44% |
| 2000 FY | 926.00 USD | -3.44% |
| 2000 Q4 | 926.00 USD | 0.0% |
| 1999 Q1 | 955.00 USD | 0.0% |
| 1999 Q2 | 1031.00 USD | 7.96% |
| 1999 FY | 959.00 USD | 0.42% |
| 1999 Q3 | 1007.00 USD | -2.33% |
| 1999 Q4 | 983.00 USD | -2.38% |
| 1998 FY | 955.00 USD | -99.92% |
| 1997 FY | 1.17 Million USD | -10.5% |
| 1996 FY | 1.31 Million USD | -24.64% |
| 1995 FY | 1.74 Million USD | -11.34% |
| 1994 FY | 1.96 Million USD | -31.74% |
| 1993 FY | 2.87 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Electromed, Inc. | 52.88 Million USD | -9.844% |
| Senseonics Holdings, Inc. | 138.22 Million USD | 57.972% |
| Catheter Precision, Inc. | 30.73 Million USD | -89.0% |
| Xtant Medical Holdings, Inc. | 92.61 Million USD | 37.275% |